| Jennifer Mary Fauntleroy, MD | |
|
11 Court Sq, Rutland, VT 05701-4030 | |
| (802) 775-1398 | |
| (802) 775-5196 |
| Full Name | Jennifer Mary Fauntleroy |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 46 Years |
| Location | 11 Court Sq, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669448981 | NPI | - | NPPES |
| OVN1669 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 042-0009568 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rutland Regional Medical Center | Rutland, VT | Hospital |
| Entity Name | Rutland Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467416206 PECOS PAC ID: 7214846377 Enrollment ID: O20040913000212 |
News Archive
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
The U.S. Food and Drug Administration today approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.
A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.
The Wall Street Journal reports: "A plan to end a program that would cut government payments to doctors is emerging as the flash point in the debate over whether President Barack Obama's effort to overhaul the health system would increase the federal budget deficit.
› Verified 1 days ago
| Entity Name | Jennifer Fauntleroy, M.d., P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669498853 PECOS PAC ID: 0042231078 Enrollment ID: O20051219000025 |
News Archive
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
The U.S. Food and Drug Administration today approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.
A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.
The Wall Street Journal reports: "A plan to end a program that would cut government payments to doctors is emerging as the flash point in the debate over whether President Barack Obama's effort to overhaul the health system would increase the federal budget deficit.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Mary Fauntleroy, MD 11 Court Sq, Rutland, VT 05701-4030 Ph: (802) 775-1398 | Jennifer Mary Fauntleroy, MD 11 Court Sq, Rutland, VT 05701-4030 Ph: (802) 775-1398 |
News Archive
Argos Therapeutics today announced two oral presentations detailing data on its soluble CD83 (sCD83) protein program at the 2010 American Transplant Congress, held May 1-5 in San Diego. The data, which were produced by Argos in collaboration with scientists from the University of Western Ontario, demonstrate that sCD83 is capable of inducing immune system tolerance to transplant grafts and suppressing an anti-donor antibody response, via a multi-faceted mechanism-of-action that impacts B and T cells, as well as dendritic cells.
The U.S. Food and Drug Administration today approved three new related products for use with diet and exercise to improve blood sugar control in adults with type 2 diabetes: Nesina (alogliptin) tablets, Kazano (alogliptin and metformin hydrochloride) tablets, and Oseni (alogliptin and pioglitazone) tablets.
A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.
The Wall Street Journal reports: "A plan to end a program that would cut government payments to doctors is emerging as the flash point in the debate over whether President Barack Obama's effort to overhaul the health system would increase the federal budget deficit.
› Verified 1 days ago
Erica M. Sweet, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Albert Cree Dr, Rutland, VT 05701 Phone: 802-775-4266 Fax: 802-786-0611 | |
Thomas Theodore Schmidt, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Albert Cree Dr, Rutland, VT 05701 Phone: 802-775-4266 Fax: 802-786-0611 | |
Saeed Ahmed, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 Fax: 802-773-4471 | |
Evelyn Susan Gerretson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 215 Stratton Rd, Rutland, VT 05701 Phone: 802-773-3386 Fax: 802-773-4578 | |
Dr. Richard P. Lango, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 73 Center St, Rutland, VT 05701 Phone: 802-775-7778 Fax: 802-775-7775 | |
Matthew D Sommons, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-747-3715 Fax: 802-773-4471 | |
Dr. Stephen M Brittain, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 254 Stratton Rd, Rutland, VT 05701 Phone: 802-775-4266 Fax: 802-786-0611 |